高级搜索
高糖、高胰岛素对乳腺癌MCF-7细胞腺苷酸活化蛋白激酶表达的影响及二甲双胍的干预研究[J]. 肿瘤防治研究, 2015, 42(04): 328-333. DOI: 10.3971/j.issn.1000-8578.2015.04.003
引用本文: 高糖、高胰岛素对乳腺癌MCF-7细胞腺苷酸活化蛋白激酶表达的影响及二甲双胍的干预研究[J]. 肿瘤防治研究, 2015, 42(04): 328-333. DOI: 10.3971/j.issn.1000-8578.2015.04.003
Effects of High Glucose and High Insulin on Adenosine Monophosphate-activated Protein Kinase Expression in Breast Cancer Cells MCF-7 and Metformin Intervention[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 328-333. DOI: 10.3971/j.issn.1000-8578.2015.04.003
Citation: Effects of High Glucose and High Insulin on Adenosine Monophosphate-activated Protein Kinase Expression in Breast Cancer Cells MCF-7 and Metformin Intervention[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 328-333. DOI: 10.3971/j.issn.1000-8578.2015.04.003

高糖、高胰岛素对乳腺癌MCF-7细胞腺苷酸活化蛋白激酶表达的影响及二甲双胍的干预研究

Effects of High Glucose and High Insulin on Adenosine Monophosphate-activated Protein Kinase Expression in Breast Cancer Cells MCF-7 and Metformin Intervention

  • 摘要: 目的 观察高糖和高胰岛素及不同浓度二甲双胍干预后乳腺癌MCF-7细胞中腺苷酸活化蛋白激酶(AMPK)的表达,探讨AMPK在糖尿病合并乳腺癌发生、发展中的作用及二甲双胍抑制糖尿病合并乳腺癌患者肿瘤生长的可能机制。方法 通过Western blot、RT-PCR方法检测MCF-7细胞在高糖、高胰岛素、高糖+高胰岛素及不同浓度二甲双胍干预后AMPK的表达水平,并应用流式细胞仪检测细胞周期。结果 高糖+高胰岛素条件下,p-AMPKα1/2及AMPKα1蛋白表达与对照组相比下降(P<0.05)。与对照组相比,高糖组中,AMPKα1、p -AMPKα 1 / 2蛋白表达和AMPKα1mRNA表达在二甲双胍处理组均增高(P<0.05);高胰岛素组中,AMPKα1、p-AMPKα1/2蛋白表达和AMPKα1 mRNA表达在二甲双胍处理组中明显增高(P<0.05);高糖+高胰岛素组中,p-AMPKα1/2、AMPKα1蛋白及AMPKα1 mRNA表达在二甲双胍处理组中均升高(P<0.05)。流式细胞仪检测细胞周期,高糖+高胰岛素共同作用下,G1期乳腺癌MCF-7细胞所占百分比有所下降,且二甲双胍的干预高糖和(或)高胰岛素作用下的MCF-7细胞,可使细胞周期停滞于G1期(P<0.05)。结论 高糖+高胰岛素可以降低乳腺癌MCF-7细胞中AMPK的表达水平,减少处于G1期细胞,而二甲双胍可以使高糖和(或)高胰岛素作用下AMPK表达增多,且使细胞停滞于G1期。

     

    Abstract: Objective To observe the effects of high glucose and/or insulin and metformin intervention on the expression of adenosine monophosphate-activated protein kinasel (AMPK) in breast cancer cells MCF-7, and to investigate the role of AMPK in the occurrence and development of diabetes combined with breast cancer, as well as the mechanism of metformin inhibiting the tumor growth. Methods Western blot and RT-PCR were applied to assess the expressions of AMPK in MCF-7 cells treated with high glucose, high insulin, high glucose plus high insulin and metformin at different concentrations, respectively. Cell cycle was detected by flow cytometry. Results The expression of AMPKα1 and p-AMPKα1/2 protein in MCF-7 cells treated with high glucose plus high insulin were significantly less than those in control group (P<0.05). In high glucose group, the expression of AMPKα1 protein treated with metformin (5, 10, 20mmol/L) were significantly increased, and the expression of p-AMPKα1/2 protein and AMPKα1 mRNA treated with metformin(2.5, 5, 10, 20mmol/L) were also significantly increased, compared with those in control group(P<0.05). In high insulin group, the expression of p-AMPKα1/2 protein and AMPKα1 mRNA treated with metformin(2.5, 5, 10, 20mmol/L) were significantly increased, and the expression of AMPKα1 protein treated with metformin (10, 20mmol/L) were significantly increased, compared with those in control group (P<0.05). In glucose plus high insulin group, the expression of p-AMPKα1/2 protein treated with metformin (5, 10, 20mmol/L) were significantly, and the expression of AMPKα1 protein treated with metformin (10, 20mM) were significantly increased, moreover, the expression of AMPKα1 mRNA treated with metformin (2.5, 5, 10, 20mM) were significantly increased, compared with those in control group (P<0.05). Compared with the control group, MCF-7 cells at G1 stage were decreased when treated with high glucose plus high insulin. And metformin-treated (20mM) cells were accumulated at G1 stage (P<0.05). Conclusion MCF-7 cells cultured with high glucose and high insulin could decrease the expression level of AMPK while metformin could increase the expression of AMPK. High glucose plus high insulin could decrease the MCF-7 cells at G1 stage, while metformin could block the cells at G1 stage.

     

/

返回文章
返回